Precision medicine and data
Prenosis Sepsis ImmunoScore
FDA De Novo-authorized AI/ML software that assigns adult emergency department or hospital patients to sepsis risk categories within a clinician-reviewed workflow.
Last updated: June 5, 2026
Back to directoryAliveCor Kardia 12L medical AI product profile
Portable AI-powered 12-lead ECG system that uses a reduced leadset and KAI 12L algorithms to support clinician-reviewed cardiac determinations.
Precision medicine and data
Best fit
Clinical teams that need portable 12-lead ECG acquisition with AI-supported cardiac findings in supervised, trained-user workflows.
- Primary use case
- FDA-cleared AI-powered handheld 12-lead resting ECG system for clinician-reviewed cardiac determinations using a simplified leadset
- Audience
- Cardiology, primary care, urgent care, emergency medicine, mobile diagnostics, and health-system teams evaluating portable ECG workflows
- Risk level
- High
- Pricing signal
- Quote-based healthcare professional pricing; request current device, software, subscription, reimbursement, integration, support, and regional availability terms.
- Official sources
- 6 official sources
Compare within workflow: Precision medicine and data · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating AliveCor Kardia 12L as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as regulated ECG hardware and algorithmic cardiac interpretation support; match use to the current FDA-cleared Kardia 12L and KAI 12L labeling rather than broad AliveCor or Kardia device claims. |
|---|---|
| Privacy | Review device, app, KardiaPro, API, cloud, NPI, patient-profile, ECG recording, support, and telehealth data flows, plus BAA, HIPAA, SOC 2, ISO 27001, HITRUST, retention, and deletion terms. |
| Evidence | Check FDA clearance materials, IFU limits, validation population, operator workflow, comparison with conventional 12-lead ECG, false positives, false negatives, and local follow-up outcomes. |
| Workflow | Best governed as clinician-reviewed ECG acquisition and interpretation support with trained operators, clear escalation pathways, conventional ECG backup, cardiology review, and monitoring for over-reliance. |
Where AliveCor Kardia 12L fits
AliveCor describes Kardia 12L as an FDA-cleared AI-powered handheld 12-lead resting ECG system for healthcare professionals; official product, IFU, privacy, security, and clearance-announcement materials describe KAI 12L determinations, simplified lead placement, KardiaPro data handling, and security certifications to verify before deployment.
Not for: Consumer self-diagnosis, unsupervised acute chest-pain triage, replacing conventional ECG review, or use outside labeling, operator training, and clinician interpretation.
What to verify before using AliveCor Kardia 12L
- Which Kardia 12L device, KAI 12L algorithm version, cardiac determinations, geography, and labeling are in scope for the deployment.
- FDA 510(k) status, intended users, patient age limits, lead-placement workflow, compatible platforms, training requirements, and contraindications.
- How ECG recordings, patient identifiers, KardiaPro or app data, cloud processing, support access, retention, and security certifications are handled under contract.
- Clinical impact on ECG acquisition time, false positives, missed findings, cardiology escalation, emergency protocols, documentation, billing, and post-deployment monitoring.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- alivecor.com / products / kardia12l
- alivecor.com / en / press
- alivecor.com / press / press_release
- alivecor.com / assets / pdf
- alivecor.com / privacy / en
- alivecor.com / security
Related medical AI products
Precision medicine and data
Anumana ECG-AI
Cardiovascular AI platform using standard 12-lead ECGs to surface signals such as low ejection fraction, pulmonary hypertension, and cardiac amyloidosis for clinician follow-up.
Precision medicine and data
Eko Health SENSORA
FDA-cleared cardiovascular detection platform that pairs Eko digital stethoscopes with AI-supported ECG and heart-sound analysis for supervised point-of-care screening.
Precision medicine and data
Philips Cardiologs Holter
Cloud-based Philips Cardiologs platform that uses deep-learning ECG analysis to support qualified clinicians reviewing Holter and ambulatory ECG recordings.